These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4454038)

  • 1. Effect of induced chronic intravascular coagulation on plasminogen activator in dogs.
    Sun NC; Bowie EJ; Titus JL; Owen CA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):189-202. PubMed ID: 4454038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter: Effect of induced chronic intravascular coagulation on plasminogen activator in dogs.
    Owen CA
    Thromb Diath Haemorrh; 1975 Sep; 34(1):309-11. PubMed ID: 1188714
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
    Moriau M; Rodhain J; Noel H; Beys-Col CD; Masure R
    Thromb Diath Haemorrh; 1974 Sep; 32(1):171-88. PubMed ID: 4281540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of immune complexes on coagulation and fibrinolysis in vivo.
    Simpson JG; Robertson AJ; Stalker AL
    Bibl Anat; 1973; 12():260-6. PubMed ID: 4790360
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasizing mammary carcinoma].
    Mischke R; Wohlsein P; Busse L; Pohlenz J
    Schweiz Arch Tierheilkd; 1998; 140(12):497-505. PubMed ID: 9863356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
    Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
    J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation and fibrinolysis systems in bronchoalveolar lavage fluid in irradiated lung of rabbits].
    Sawada M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1515-21. PubMed ID: 8121087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs.
    Feldman BF; Madewell BR; O'Neill S
    J Am Vet Med Assoc; 1981 Jul; 179(2):151-4. PubMed ID: 7263467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and fibrinolysis in the dog.
    Cade JF; Robinson TF
    Can J Comp Med; 1975 Jul; 39(3):296-8. PubMed ID: 1139411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
    Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.
    Gando S; Kameue T; Nanzaki S; Nakanishi Y
    Thromb Haemost; 1996 Feb; 75(2):224-8. PubMed ID: 8815564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.